POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

U.S. sluggish in testing Wuhan coronavirus, says Science

Christian Fernsby |
The United States bungled its coronavirus testing as it has been slow in an attempt to develop reliable diagnostic tests and use them widely, the journal Science reported.

Article continues below



Topics: U.S.    WUHAN    CORONAVIRUS   

The U. S. Centers for Disease Control and Prevention (CDC) has done only 459 tests by the end of February, according to the journal.

It was partially because the CDC initially set strict criteria for novel coronavirus testing, which limited the availability to people who had returned from an affected country or had been known to be in contact with someone with the virus. After it changed the criteria by the end of February, the confirmed cases in the country kept increasing.

In addition, part of CDC's testing kits went awry. Although it developed the RT-PCR tools in early February, it turned out that some of them contained a faulty reagent, thus producing inconclusive results and further slowing down the testing efforts of local health departments.

"There have been blunders, and there could be an underlying catastrophe that we don't know about," said epidemiologist Michael Mina, who helps run a microbiology testing lab at Brigham and Women's Hospital.

Labs like Mina's were not allowed to test novel coronavirus without approval until U.S. Food and Drug Administration loosened the limits on Feb. 29.

When the United States declared the outbreak a public health emergency on Jan. 31, a bureaucratic process kicked in that requires FDA's "emergency use approval" for any tests, according to Science.

"The declaration of a public health emergency did exactly what it shouldn't have. It limited the diagnostic capacity of this country," Mina says. "It's insane."

"If we had the ability to test earlier, I'm sure we would have identified patients earlier," said Jeffrey Duchin, health officer for Seattle and King County in Washington State.

Washington state announced on Monday four more people died from the coronavirus, bringing the number of deaths in the country to six, all in Washington.

Over 100 Wuhan coronavirus cases have been confirmed so far in the United States.


What to read next

CDC raises Wuhan coronavirus travel alert, Hebei confirms first death outside epicentre
2019-nCoV, extremely dangerous type of coronavirus that spreads fast
Three drugs fairly effective on Wuhan coronavirus on cellular level